Richard Chubet

644 total citations
8 papers, 542 citations indexed

About

Richard Chubet is a scholar working on Molecular Biology, Biotechnology and Infectious Diseases. According to data from OpenAlex, Richard Chubet has authored 8 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Biotechnology and 3 papers in Infectious Diseases. Recurrent topics in Richard Chubet's work include Transgenic Plants and Applications (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). Richard Chubet is often cited by papers focused on Transgenic Plants and Applications (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). Richard Chubet collaborates with scholars based in United States, Australia and Canada. Richard Chubet's co-authors include Bill Brizzard, Douglas L. Vizard, Manon Cox, Keyang Wang, Wafaa Mahmoud, Karl E. Anderson, Kathleen M. Holtz, Clifton E. McPherson, M Petrić and Zhifeng Zhou and has published in prestigious journals such as Vaccine, BioTechniques and Human Vaccines & Immunotherapeutics.

In The Last Decade

Richard Chubet

8 papers receiving 504 citations

Peers

Richard Chubet

MB

ID

RNMI

EPIDE

IMMUN

Lynne J. Lawrence Australia

Anne Marie Szilvay Norway

Louis E.-C. Leong Singapore

Ilja Bontjer Netherlands

Cheng‐Yu Chung United States

Miriam Cohen United States

Carl A. Ascoli United States

Christopher G. Ullman United Kingdom

Ryan J. Malonis United States

Sarah A. Clark United States

Lynne J. Lawrence Australia

Richard Chubet

479 ×1.6

MB

85 ×0.6

ID

195 ×1.5

RNMI

275 ×2.2

EPIDE

77 ×1.0

IMMUN

Citations per year, relative to Richard Chubet Richard Chubet (= 1×) peers Lynne J. Lawrence

Countries citing papers authored by Richard Chubet

Since Specialization

Citations

This map shows the geographic impact of Richard Chubet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Chubet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Chubet more than expected).

Fields of papers citing papers by Richard Chubet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Chubet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Chubet. The network helps show where Richard Chubet may publish in the future.

Co-authorship network of co-authors of Richard Chubet

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Chubet. A scholar is included among the top collaborators of Richard Chubet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Chubet. Richard Chubet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Chubet, Richard, et al.. (2022). A novel SARS-CoV-2 subunit vaccine engineered on an immune-activating platform technology. Human Vaccines & Immunotherapeutics. 18(4). 2062971–2062971. 1 indexed citations

2.

McPherson, Clifton E., Richard Chubet, Yoshikazu Honda‐Okubo, et al.. (2016). Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant. Methods in molecular biology. 1403. 269–284. 25 indexed citations

3.

Bonafé, Nathalie, Joseph A. Rininger, Richard Chubet, et al.. (2008). A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells. Vaccine. 27(2). 213–222. 26 indexed citations

4.

Zhou, Zhifeng, Penny Post, Richard Chubet, et al.. (2006). A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice. Vaccine. 24(17). 3624–3631. 70 indexed citations

5.

Wang, Keyang, Kathleen M. Holtz, Karl E. Anderson, et al.. (2005). Expression and purification of an influenza hemagglutinin—one step closer to a recombinant protein-based influenza vaccine. Vaccine. 24(12). 2176–2185. 119 indexed citations

6.

Brizzard, Bill & Richard Chubet. (1997). Epitope Tagging of Recombinant Proteins. Current Protocols in Neuroscience. 0(1). Unit 5.8–Unit 5.8. 9 indexed citations

7.

Chubet, Richard & Bill Brizzard. (1996). Vectors for Expression and Secretion of FLAG Epitope-Tagged Proteins in Mammalian Cells. BioTechniques. 20(1). 136–141. 78 indexed citations

8.

Brizzard, Bill, Richard Chubet, & Douglas L. Vizard. (1994). Immunoaffinity purification of FLAG epitope-tagged bacterial alkaline phosphatase using a novel monoclonal antibody and peptide elution.. PubMed. 16(4). 730–5. 214 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact